As an anticancer vaccine, BFGF-OMVs can break the tolerance of B cells, so that persistent and high levels of anti-BFGF autoantibodies can be produced by the immune system, which exhibits persistent, efficient, and multifunctional tumor suppression effects [99]. The gene discussed is FGF2; the disease is neoplasm.